New device AVELI tackles cellulite and fibrosis in liposuction patients
NCT ID NCT06791564
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a device called AVELI to safely reduce cellulite and fibrous tissue in 130 people undergoing body contouring surgery. Researchers measured safety, patient satisfaction, and appearance improvements over 9 months. The goal was to see if adding AVELI to standard liposculpture improves aesthetic results without serious side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CELLULITE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dhara Clinic
Bogotá, DC, Colombia
-
Miami Aesthetic
Miami, Florida, 33131, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a CO2 gel heal liposuction bruises faster?
- New injection aims to smooth cellulite dimples
- Can adding a simple skin snip boost cellulite treatment?
- Could a gel injection smooth away cellulite? new trial investigates
- New shot targets cellulite: small study tests qwo on butt and thighs
- Scientists hunt for clues to stop rare, deadly scleroderma